Patent ID: 11884653
Assignee: PURDUE RESEARCH FOUNDATION
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 7:
8. A method for treating a patient with an infection with Ebola virus or Marburg virus, comprising the step of administering a therapeutically effective amount of one or more compounds, together with one or more carriers, diluents, or excipients, to a patient in need of relief from said infection, the compound having formula (I):, or a pharmaceutically acceptable salt thereof, wherein
A is CR2, CH2, S, NH, or NR, wherein R is alkyl;
B is hydrogen (H), deuterium (D), or fluorine (F);
X is CR2, CH2, CHR, S, NH, or NR, wherein R is unsubstituted alkyl;
Y is O, CF2, CH2, CHR, S, NH, or NR, wherein R is an alkyl;
R1 is hydrogen, alkyl, alkylamide, alkenyl, alkenylamide, alkenylamino, alkynyl, alkynylamide, alkynylamino, heterocyclyl, cycloalkyl, cycloalkenyl, acyl, aryl, heteroaryl, arylalkyl, arylalkenyl, or arylalkynyl;
R2, R3, and R4 are each independently selected from the group consisting of hydrogen, deuterium, —CN, and a halo.